GE vs SUPN · P/E 44, rev $13.35B vs rev $426.8M
GE Aerospace (GE) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported SUPN revenue for 2026-06-30 was $426.8M. Net income was -$60.7M. SUPN currently screens at market cap $2.53B.
GE currently screens at market cap $373.04B and trailing P/E 44.4. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the GE and SUPN stock pages for the full models.
Not investment advice.